Back to Search
Start Over
PCN80 Cost-Effectiveness of Eml4-Alk Gene Targeted First-Line Ceritinib Treatment Among Patients With Advanced Alk-Positive Non–Small Cell Lung Cancer
- Source :
- Value in Health. (3):A203
- Publisher :
- Published by Elsevier Inc.
- Subjects :
- health care economics and organizations
Subjects
Details
- Language :
- English
- ISSN :
- 10983015
- Issue :
- 3
- Database :
- OpenAIRE
- Journal :
- Value in Health
- Accession number :
- edsair.core.ac.uk....8155d7390ba2fbb7249c96f7a4f5049e
- Full Text :
- https://doi.org/10.1016/j.jval.2015.03.1177